In South Korea, mandatory wearing of masks and practicing social distancing with masks on public transport during peak hours reduced infection rates by 93.5 and 98.1%, respectively, according to a new modeling study in Science Advances. fcld.ly/vpcxbtg

“A genome-wide CRISPR activation screen identifies PRRX2 as a regulator of enzalutamide resistance in prostate cancer” is online today in Cancer Research and being presented at #AACR22 now. Visit Yara Rodriguez Zabala at the poster (Section 16 Board 7) and read the article! aacrjournals.org/cancerres/arti…

On Fri., May 13, hear from Richard Pazdur, MD, Director of FDA Oncology, and an expert panel from Lurie Cancer Center on “Drug Development from Bench to Bedside.” View the agenda and register for our 2022 TRIST Symposium on Northwestern’s Chicago campus at: cancer.northwestern.edu/events/profess…

Congratulations, Yara Rodriguez, PhD, on her final thesis! 🥳

A MYC inhibitor operates selectively, reducing expression of genes that fuel cell proliferation and alter the #epigenome, according to Drs. Debabrata Chakravarti & Sarki Abdulkadir Lurie Cancer Center, co-senior authors of the study in Science Advances bit.ly/3tdf3L2

The Polsky Urologic Cancer Institute of the Lurie Cancer Center of Northwestern at NMH has chosen six faculty members to receive the Research Award to support clinical, laboratory or translational projects to advance knowledge & innovative research in the field of urologic #oncology.

An opportunity for early-stage investigators from underrepresented groups. #diversity #CancerResearch #CancerMoonshot

Fish in a drop of water on a lotus leaf: #biology

Nice work and years of dedication by Laura Soucek PEPTOMYC. So glad to see Omomyc in the clinic. Also, very happy to see Sarki Abdulkadir Lurie Cancer Center work advancing small molecules myc inhibitors to clinic. MYC is not "undruggable", it's just "not drugged yet"

Congrats!! TACTICAL Award from Prostate Cancer Foundation to my mentors and academic bestie at Lurie Cancer Center !! Sarki Abdulkadir Gary Schiltz Maha Hussain and Sarah Fenton Congrats to Arul Chinnaiyan and the UMich team too.

Today’s annual Members Retreat led off with updates on our impact from Lurie Cancer Center Director, Leonidas Platanias, MD, and Associate Director of Diversity, Equity & Inclusion, Sarki Abdulkadir — followed by breakout sessions to discuss our progress and learn from each other.

Please join us in congratulating Mario Shields, PhD, on receiving the Lurie Cancer Center Diversity Scholars Award! This inaugural award will actively support his research aimed at understanding pancreatic cancer development and progression. Learn more: cancer.northwestern.edu/news/2023/shie…

We're excited to share #Science2StartupSpotlight Sarki Abdulkadir, MD, PhD, Professor of Urology & Pathology, Northwestern. Sarki's presentation will focus on small molecule MYC inhibitors leveraging unique insights into MYC structure and function. Follow along for updates!

Great presentation by ⁦Sarki Abdulkadir⁩ discussing our MYC inhibitor project. Very exciting to see this work discussed with the biotech/VC community.

Sarki Abdulkadir in his element. 😍

Congratulations to Lurie Cancer Center’s Mario Shields, PhD, named one of the country’s first 11 National Cancer Institute Cancer Moonshot Scholars! Learn more about his research and the program: cancer.northwestern.edu/news/2023/shie… #PancreaticCancer

I am thrilled to announce that I've been selected as an HHMI Hanna H. Gray Fellow. It's an absolute honor to be part of this amazing community. Huge thanks to my postdoc mentor Stegmaier Lab, PhD advisor, Sarki Abdulkadir, and my colleagues Dana-Farber News and Northwestern Feinberg School of Medicine!

In this episode of our #BreakthroughsPodcast, Sarki Abdulkadir discusses the discovery of compounds that block the 'undruggable' MYC gene, making #ProstateCancer tumors sensitive to hormone therapy. 🔗 spr.ly/6019o8Iml